Boc-Asp(OcHex)-OHCAS# 73821-95-1 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 73821-95-1 | SDF | Download SDF |
| PubChem ID | 7009416 | Appearance | Powder |
| Formula | C15H25NO6 | M.Wt | 315.4 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | (2S)-4-cyclohexyloxy-2-[(2-methylpropan-2-yl)oxycarbonylamino]-4-oxobutanoic acid | ||
| SMILES | CC(C)(C)OC(=O)NC(CC(=O)OC1CCCCC1)C(=O)O | ||
| Standard InChIKey | NLPQIWFEEKQBBN-NSHDSACASA-N | ||
| Standard InChI | InChI=1S/C15H25NO6/c1-15(2,3)22-14(20)16-11(13(18)19)9-12(17)21-10-7-5-4-6-8-10/h10-11H,4-9H2,1-3H3,(H,16,20)(H,18,19)/t11-/m0/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
Boc-Asp(OcHex)-OH Dilution Calculator
Boc-Asp(OcHex)-OH Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 3.1706 mL | 15.8529 mL | 31.7058 mL | 63.4115 mL | 79.2644 mL |
| 5 mM | 0.6341 mL | 3.1706 mL | 6.3412 mL | 12.6823 mL | 15.8529 mL |
| 10 mM | 0.3171 mL | 1.5853 mL | 3.1706 mL | 6.3412 mL | 7.9264 mL |
| 50 mM | 0.0634 mL | 0.3171 mL | 0.6341 mL | 1.2682 mL | 1.5853 mL |
| 100 mM | 0.0317 mL | 0.1585 mL | 0.3171 mL | 0.6341 mL | 0.7926 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Boc-Asp(OcHex)-OH
- 2,6-Dimethyl-7-octene-2,3,6-triol
Catalog No.:BCN4292
CAS No.:73815-21-1
- Orientin 2''-O-p-trans-coumarate
Catalog No.:BCN2792
CAS No.:73815-15-3
- S-Sulfo-L-cysteine sodium salt
Catalog No.:BCC6558
CAS No.:7381-67-1
- Bergamotine
Catalog No.:BCN2733
CAS No.:7380-40-7
- Trimethoprim
Catalog No.:BCC4873
CAS No.:738-70-5
- Kihadanin B
Catalog No.:BCN3441
CAS No.:73793-68-7
- 360A iodide
Catalog No.:BCC1308
CAS No.:737763-37-0
- N-(4-Aminobenzoyl)-β-alanine
Catalog No.:BCC9056
CAS No.:7377-08-4
- Acanthoside B
Catalog No.:BCN4291
CAS No.:7374-79-0
- Broussonin A
Catalog No.:BCN4592
CAS No.:73731-87-0
- Broussonin B
Catalog No.:BCN4593
CAS No.:73731-86-9
- Fmoc-Thr-OH
Catalog No.:BCC3549
CAS No.:73731-37-0
- Boc-Glu(OcHex)-OH
Catalog No.:BCC3390
CAS No.:73821-97-3
- 3-Amino-9H-pyrido[3,4-b]indole
Catalog No.:BCC8617
CAS No.:73834-77-2
- Foresaconitine
Catalog No.:BCC8173
CAS No.:73870-35-6
- H-His-OMe.2HCl
Catalog No.:BCC2956
CAS No.:7389-87-9
- Hispidone
Catalog No.:BCN4293
CAS No.:73891-72-2
- Isolimonexic acid
Catalog No.:BCN7141
CAS No.:73904-93-5
- 7,8-Dimethoxy-1,3-dihydro-2H-3-benzazepin-2-one
Catalog No.:BCC8774
CAS No.:73942-87-7
- Cilostazol
Catalog No.:BCC2291
CAS No.:73963-72-1
- Kamebakaurin
Catalog No.:BCN8040
CAS No.:73981-34-7
- Ethambutol
Catalog No.:BCC5195
CAS No.:74-55-5
- L-Arginine
Catalog No.:BCN2691
CAS No.:74-79-3
- Mosloflavone
Catalog No.:BCN6796
CAS No.:740-33-0
Solid-phase synthesis of protected peptides using new cobalt(III) ammine linkers.[Pubmed:8407108]
Int J Pept Protein Res. 1993 Aug;42(2):138-54.
Cobalt(III) ammine complexes of the type cis-[CoL4(4-AMB)O-AA-Boc](CF3SO3)2, where L4 = bisethylenediamine (en)2 or tetraammine (NH3)4, and 4-AMB = 4-(aminomethyl)benzoic acid, have been synthesized and used as linkers to polystyrene resins for solid-phase synthesis of protected peptides. Boc/t-Bu-protected [Leu5]enkephalin was assembled on the two different Co(III) resins, and then cleaved from the resins by reduction of the Co(III) center in 93-96% yield. HPLC-purified protected [Leu5]enkephalin was obtained in 67-69% overall yield and characterized by amino acid analysis and 1H NMR. Stepwise synthesis on the Co(en)2-resin was also used in the assembly of Boc-Asp(OcHex)-Arg(Mts)-Gly-Asp(OcHex)-Ala-Pro-Lys(2Cl-Z)-Gl y-OH, a sequence from collagen alpha 1 Type 1. The protected peptide was cleaved from the Co(III) resin in 74% yield, and the HPLC-purified nonapeptide was characterized by amino acid analysis, 1H NMR and liquid secondary-ion mass spectrometry (LSIMS). New routes are described for the synthesis of isomerically pure Co(III) anchor complexes. The Co(III) resins were found to be compatible with both the tert-butyloxycarbonyl (Boc) and the 9-fluorenylmethoxycarbonyl (Fmoc) N alpha-protecting group strategies used in solid-phase peptide synthesis.
